Ronald Blue Trust, Inc. Cooper Companies, Inc. Transaction History

Ronald Blue Trust, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$306.88 - $380.0 $10,433 - $12,920	34 Added 54.84%	96 $30,000
Q3 2023 Oct 11, 2023	BUY	$315.92 - $397.36 $15,164 - $19,073	48 Added 342.86%	62 $24,000
Q2 2023 Jul 14, 2023	SELL	$346.15 - $392.09 $11,422 - $12,938	-33 Reduced 70.21%	14 $5,000
Q1 2023 Apr 17, 2023	BUY	$323.56 - $373.36 $4,853 - $5,600	15 Added 46.88%	47 $15,000
Q4 2022 Jan 17, 2023	BUY	$248.67 - $334.17 $6,465 - $8,688	26 Added 433.33%	32 $8,000
Q3 2022 Oct 21, 2022	SELL	$263.81 - $337.27 $1,846 - $2,360	-7 Reduced 53.85%	6 $2,000
Q2 2022 Aug 09, 2022	BUY	$301.4 - $428.42 $3,918 - $5,569	13 New	13 $6,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

Stay updated on Ronald Blue Trust, Inc. with notifications on news.